Pfizer/BioNTech Covid-19 vaccine safe for primary schoolkids


By AGENCY

Clinical trial results have demonstrated that the Pfizer-BioNTech Covid-19 vaccine is safe to be used in children aged five to 11 years. — AFP

Pfizer and BioNTech said on Sept 20 (2021) that clinical trial results showed their Covid-19 vaccine is safe and produces a robust immune response in children aged five to 11.

The vaccine would be administered at a lower dosage than for people over 12, they said.

Unlock 30% Savings on Ad-Free Access Now!

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Health

Faced with a terminal illness themselves, doctors prefer assisted dying
Always having cold feet? You could have narrowed arteries
New blood test can detect early dementia
The current heatwave is causing plenty of health woes
Bet you didn't know there's a link between the mouth and digestive problems
Elder abuse: spot the warning signs
Don't dismiss the warning signs of a ministroke
Drugs are intended to cure, instead they're becoming water contaminants
Your pulse can tell a lot about the state of your heart
Itching could potentially be a sign of ill health

Others Also Read